Isoeucommin A attenuates kidney injury in diabetic nephropathy through the Nrf2/HO‐1 pathway
Qi Huang,Dong‐Sheng Ouyang,Qiong Liu
DOI: https://doi.org/10.1002/2211-5463.13251
2021-07-24
FEBS Open Bio
Abstract:<p>Diabetic nephropathy (DN) is a common complication in patients with diabetes and a leading cause of mortality. The management of DN in the clinic still remains a challenge. Therefore, the identification of novel compounds for DN treatment and their characterization in pre-clinical DN models is crucial. Isoeucommin A is a lignan compound isolated from <i>Eucommia ulmoides</i> Oliv, which has not been studied in detail. Our aim was to investigate the effect of Isoeucommin A in DN and to elucidate the molecular mechanisms though which Isoeucommin A acts <i>in vitro</i> and <i>in vivo</i>.</p><p>We first isolated and purified Isoeucommin A by microporous resin column chromatography and studied the mass spectrogram, as well as the structure of Isoeucommin A by HRESIMS and NMR respectively. We further established an <i>in vivo</i> rat DN model and measured the changes of blood glucose (BG), body weight, kidney index (KI), blood urea nitrogen (BUN), creatinine (CRE), glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD), albumin (ALB), and urinary ALB to CRE ratios (UACR) upon treatment with Isoeucommin A . Additionally, we measured SOD, MDA, p-GSK-3β, GSK-3β, Nrf2, and HO-1 levels by qRT-PCR and western blot and estimated cell viability by a MTT assay..</p><p>After Isoeucommin A treatment, body weight, as well as SOD, GSH, HO-1, and Nrf2 expression levels in DN rats increased in a dose dependent manner. On the other hand, the levels of BG, KI, BUN, CRE, UACR, TNF-α, IL-1β, IL-6, and MDA decreased significantly. Additionally, Isoeucommin A protected H<sub>2</sub>O<sub>2</sub>-stimulated renal tubular epithelial cells (RTECs) from oxidative stress and activated Nrf2/HO-1 signaling pathway in high glucose-stimulated human renal mesangial cells (HRMCs).</p><p>In conclusion, Isoeucommin A could alleviate inflammation and oxidative stress in <i>in vitro</i> and <i>in vivo</i> DN models and thus attenuate kidney injury by activating the Nrf2/HO-1 signaling pathway. Isoeucommin A could have the potential to be used as an effective drug for the treatment of DN.</p>
biochemistry & molecular biology